User profiles for Jacqueline K. Harris
 | Jacqueline HarrisPhD Student, Computing Science, University of Alberta Verified email at ualberta.ca Cited by 384 |
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report
Finding a clinically useful neuroimaging biomarker that can predict treatment response in
patients with major depressive disorder (MDD) is challenging, in part because of poor …
patients with major depressive disorder (MDD) is challenging, in part because of poor …
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in …
…, S Hassel, SC Strother, JK Harris… - …, 2020 - nature.com
Anhedonia is thought to reflect deficits in reward processing that are associated with abnormal
activity in mesocorticolimbic brain regions. It is expressed clinically as a deficit in the …
activity in mesocorticolimbic brain regions. It is expressed clinically as a deficit in the …
Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants
Subtle changes in hippocampal volumes may occur during both physiological and
pathophysiological processes in the human brain. Assessing hippocampal volumes manually is a …
pathophysiological processes in the human brain. Assessing hippocampal volumes manually is a …
Reduced accuracy accompanied by reduced neural activity during the performance of an emotional conflict task by unmedicated patients with major depression: A …
Methods We studied 48 MDD and 30 HC who performed an emotional conflict task in a
functional magnetic resonance imaging (fMRI) scanner. Results On the emotional conflict task, …
functional magnetic resonance imaging (fMRI) scanner. Results On the emotional conflict task, …
Exploring brain connectivity changes in major depressive disorder using functional‐structural data fusion: A CAN‐BIND‐1 study
There is a growing interest in examining the wealth of data generated by fusing functional
and structural imaging information sources. These approaches may have clinical utility in …
and structural imaging information sources. These approaches may have clinical utility in …
Structural covariance pattern abnormalities of insula in major depressive disorder: A CAN-BIND study report
Background and methods Investigation of the insula may inform understanding of the
etiopathogenesis of major depressive disorder (MDD). In the present study, we introduced a novel …
etiopathogenesis of major depressive disorder (MDD). In the present study, we introduced a novel …
[HTML][HTML] Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report
Many previous intervention studies have used functional magnetic resonance imaging (fMRI)
data to predict the antidepressant response of patients with major depressive disorder (…
data to predict the antidepressant response of patients with major depressive disorder (…
Cerebello-limbic functional connectivity patterns in youth at clinical high risk for psychosis
Youth at clinical high risk (CHR) for psychosis can present not only with characteristic
attenuated psychotic symptoms but also may have other comorbid conditions, including anxiety …
attenuated psychotic symptoms but also may have other comorbid conditions, including anxiety …
Baseline functional connectivity in resting state networks associated with depression and remission status after 16 weeks of pharmacotherapy: A CAN-BIND Report
Understanding the neural underpinnings of major depressive disorder (MDD) and its
treatment could improve treatment outcomes. So far, findings are variable and large sample …
treatment could improve treatment outcomes. So far, findings are variable and large sample …
Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN …
Background Identifying objective biomarkers can assist in predicting remission/non-remission
to treatment, improving remission rates, and reducing illness burden in major depressive …
to treatment, improving remission rates, and reducing illness burden in major depressive …